<VariationArchive VariationID="812486" VariationName="NM_177924.5(ASAH1):c.174dup (p.Tyr59fs)" VariationType="Duplication" Accession="VCV000812486" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2020-02-16" MostRecentSubmission="2020-02-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="800742" VariationID="812486">
      <GeneList>
        <Gene Symbol="ASAH1" FullName="N-acylsphingosine amidohydrolase 1" GeneID="427" HGNC_ID="HGNC:735" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18055992" stop="18084961" display_start="18055992" display_stop="18084961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="17913924" stop="17942506" display_start="17913924" display_stop="17942506" Strand="-" />
          </Location>
          <OMIM>613468</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_177924.5(ASAH1):c.174dup (p.Tyr59fs)</Name>
      <CanonicalSPDI>NC_000008.11:18071341:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18071341" stop="18071342" display_start="18071341" display_stop="18071342" variantLength="1" positionVCF="18071341" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="17928850" stop="17928851" display_start="17928850" display_stop="17928851" variantLength="1" positionVCF="17928850" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>Y75fs</ProteinChange>
      <ProteinChange>Y82fs</ProteinChange>
      <ProteinChange>Y59fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.17928853dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.17928853dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.18071344dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.18071344dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008985.2" sequenceAccession="NG_008985" sequenceVersion="2" change="g.18657dup">
            <Expression>NG_008985.2:g.18657dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127505.3" sequenceAccession="NM_001127505" sequenceVersion="3" change="c.243dup">
            <Expression>NM_001127505.3:c.243dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120977.1" sequenceAccession="NP_001120977" sequenceVersion="1" change="p.Tyr82fs">
            <Expression>NP_001120977.1:p.Tyr82fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363743.2" sequenceAccession="NM_001363743" sequenceVersion="2" change="c.-22dup">
            <Expression>NM_001363743.2:c.-22dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004315.6" sequenceAccession="NM_004315" sequenceVersion="6" change="c.222dup">
            <Expression>NM_004315.6:c.222dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004306.3" sequenceAccession="NP_004306" sequenceVersion="3" change="p.Tyr75fs">
            <Expression>NP_004306.3:p.Tyr75fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_177924.5" sequenceAccession="NM_177924" sequenceVersion="5" change="c.174dup" MANESelect="true">
            <Expression>NM_177924.5:c.174dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_808592.2" sequenceAccession="NP_808592" sequenceVersion="2" change="p.Tyr59fs">
            <Expression>NP_808592.2:p.Tyr59fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_177924.5" sequenceAccession="NM_177924" sequenceVersion="5" change="c.174_175insC" MANESelect="true">
            <Expression>NM_177924.5:c.174_175insC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="771718522" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_177924.5(ASAH1):c.174dup (p.Tyr59fs) AND Farber lipogranulomatosis" Accession="RCV001003316" Version="2">
        <ClassifiedConditionList TraitSetID="43">
          <ClassifiedCondition DB="MedGen" ID="C0268255">Farber lipogranulomatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-02-16" MostRecentSubmission="2020-02-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="DOI">10.1002/jimd.12043</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="43" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14121" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Farber's lipogranulomatosis</ElementValue>
                <XRef ID="79935000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Farber's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Farber disease</ElementValue>
                <XRef ID="333" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Farber lipogranulomatosis</ElementValue>
                <XRef ID="MONDO:0009218" DB="MONDO" />
                <XRef ID="79935000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceramidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acid ceramidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AC deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-Laurylsphingosine deacylase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FRBRL</ElementValue>
                <XRef Type="MIM" ID="228000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ASAH1-related disorders ranges from Farber disease (FD) to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). Classic FD is characterized by onset in the first weeks of life of painful, progressive deformity of the major joints; palpable subcutaneous nodules of joints and mechanical pressure points; and a hoarse cry resulting from granulomas of the larynx and epiglottis. Life expectancy is usually less than two years. In the other less common types of FD, onset, severity, and primary manifestations vary. SMA-PME is characterized by early-childhood-onset progressive lower motor neuron disease manifest typically between ages three and seven years as proximal lower-extremity weakness, followed by progressive myoclonic and atonic seizures, tremulousness/tremor, and sensorineural hearing loss. Myoclonic epilepsy typically begins in late childhood after the onset of weakness and can include jerking of the upper limbs, action myoclonus, myoclonic status, and eyelid myoclonus. Other findings include generalized tremor, and cognitive decline. The time from disease onset to death from respiratory complications is usually five to 15 years.</Attribute>
                <XRef ID="NBK488189" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6426" />
                <XRef ID="6426" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29595935</ID>
                <ID Source="BookShelf">NBK488189</ID>
              </Citation>
              <XRef ID="333" DB="Orphanet" />
              <XRef ID="C0268255" DB="MedGen" />
              <XRef ID="MONDO:0009218" DB="MONDO" />
              <XRef Type="MIM" ID="228000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2288696" SubmissionDate="2019-07-15" DateLastUpdated="2020-02-16" DateCreated="2020-02-16">
        <ClinVarSubmissionID localKey="Pt 37.1 NM_177924.5(ASAH1):c.174_175insC" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001161400" DateUpdated="2020-02-16" DateCreated="2020-02-16" Type="SCV" Version="1" SubmitterName="Medical Affairs, Dicerna Pharmaceuticals" OrgID="507035" OrganizationCategory="other" OrgAbbreviation="MA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="DOI">10.1002/jimd.12043</ID>
          </Citation>
          <Comment>Variant c.174_175insC has been classified as pathogenic. Patient described in Ehlert et al., 2017, DOI: 10.1002/jimd.12043, was diagnosed with severe Farber disease and compound heterozygous ASAH1 variants, c.174_175insC and c.626G&gt;A, were identified. Variant c.174_175insC results in a single nucleotide insertion causing in a premature stop codon at position 64. The severe phenotype in this patient can be attributed to truncation and inactivation of this enzyme. The patient received a HSCT as the only present treatment option at 1.3 years of age and died shortly after transplant due to acute respiratory distress.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <Description>ASAH1 sequencing. ASAH1 variants describe for this patient: DOI: 10.1002/jimd.12043</Description>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASAH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_177924.5:c.174_175insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="228000" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>Patient has ASAH1 compound variants including (c.174_175insC) and (c.626G&gt;A)</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB5958214</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2288696" TraitType="Disease" MappingType="XRef" MappingValue="228000" MappingRef="OMIM">
        <MedGen CUI="C0268255" Name="Farber lipogranulomatosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

